FEASTERVILLE, Pa.--(BUSINESS WIRE)--Despite generic intrusion into one of its biggest markets, global restructuring and much publicized Vioxx-related lawsuits, Merck & Co.’s strong customer relationships and support propelled the company into the top 3 pharmaceutical/biotech companies that best met the overall needs of influential managed care decision makers, according to Cognet-X’s PAR-Rx (Promotional Assessment Research) Report™.
